NCT03508934View on ClinicalTrials.gov

Continuous Glucose Monitoring Devices in Hospitalized Veterans With Diabetes

NAActive, not recruitingINTERVENTIONAL
Enrollment

218

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

July 11, 2025

Study Completion Date

December 31, 2025

Conditions
Diabetes Mellitus, Type 2Hypoglycemia
Interventions
DEVICE

GTS (Continuous Glucose Monitoring)

Hospitalized patients with DM2 will be monitored with Glucose Telemetry System (GTS)

OTHER

POC (Point of Care)

Hospitalized patients with DM2 will be monitored with POC (Point of Care) blood glucose levels.

Trial Locations (1)

21201

Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore

All Listed Sponsors
lead

VA Office of Research and Development

FED